CoDon AG (CNW) NPV

Sell:€0.01Buy:€0.01€0.00 (11.76%)

Prices delayed by at least 15 minutes
Sell:€0.01
Buy:€0.01
Change:€0.00 (11.76%)
Prices delayed by at least 15 minutes
Sell:€0.01
Buy:€0.01
Change:€0.00 (11.76%)
Prices delayed by at least 15 minutes

Company Information

About this company

CoDon AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. It also offers biopsy, cultivation, transplantation, rehabilitation and others.

Key people

Thommy Staehlin
Independent Chairman of the Supervisory Board
Barbara Sickmueller
Independent Deputy Chairwoman of the Supervisory Board
Tilmann Bur
Member of the Management Board
Hansjoerg Bullinger
Independent Member of the Supervisory Board
Thomas Krause
Independent Member of the Supervisory Board
Beatrix Bauerfeind-Johnson
Member of the Supervisory Board
Click to see more

Key facts

  • EPIC
    -
  • Location
    Germany
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    DE000A3E5C08
  • Market cap
    €227,150.00
  • Employees
    134
  • Shares in issue
    26.72m
  • Exchange
    Frankfurt Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.